C. Chapman

A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home‐HF study

Stephen Morris, Michael Roughton, M. Cowie, 2009, European journal of heart failure.

Treating iron deficiency in patients with gastrointestinal disease: Risk of re-attendance in secondary care

R. Tham, C. Chapman, S. Keshav, 2017, PloS one.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

A. Bolger, C. Chapman, J. O'leary, 2006, Journal of the American College of Cardiology.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

626 The HOME-HF Study: A multi-centre randomised controlled trial of home telemonitoring in a general heart failure population of elderly patients with co-morbidity

M. Cowie, M. Roughton, S. Rosen, 2008 .

The Home Heart Failure Study (Home-HF): A randomised controlled trial of home telemonitoring of heart failure patients at high risk of readmission and death

S. Rosen, S. Dubrey, J. Riley, 2008 .